Drug Shortage Report for AURO-QUINAPRIL HCTZ
| Report ID | 166763 |
| Drug Identification Number | 02473321 |
| Brand name | AURO-QUINAPRIL HCTZ |
| Common or Proper name | QUINAPRIL HCTZ |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE QUINAPRIL |
| Strength(s) | 25MG 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 2x14's Blst |
| ATC code | C09BA |
| ATC description | ACE INHIBITORS, COMBINATIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-08-12 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2022-08-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2022-08-15 | French | Compare |
| v1 | 2022-08-15 | English | Compare |
Showing 1 to 2 of 2